SNYR
Synergy CHC Corp.Company with tickers: SNYR
CIK
1562733
CUSIP
87165D208
Shares Outstanding
14,899,883
Website
https://www.synergychc.com
Investor Relations
https://investors.synergychc.com/
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $5,492,705 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $1,521,910 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Gross Profit | $3,970,795 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Expenses | $4,537,915 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | — | ||||
| Operating Income | $-567,120 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-2,568,899 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.23 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.23 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Segment (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Nutraceuticals | $42,753,052 | $33,392,094 | $29,731,664 |
| Beverages | — | $1,425,239 | $631,332 |
| Consumer Goods | $24,581 | $16,910 | $17,987 |
By Geography (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| United States | $40,621,985 | $30,831,188 | $27,318,377 |
| Canada | — | $3,926,370 | $2,418,056 |
| Mexico | — | $3,638 | $623,660 |
| Other | — | $73,047 | $20,716 |
| Foreign Countries | $2,155,648 | $4,003,055 | — |
By Product & Service (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Retail | $31,775,727 | $26,473,946 | $22,249,424 |
| Online | $11,001,906 | $8,360,297 | $8,131,385 |
| License Revenue | — | — | $2,900,000 |